cgs 15943 and mrs 1220
cgs 15943 has been researched along with mrs 1220 in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jacobson, KA; Ji, XD; Kim, YC | 1 |
| Chang, L; de Zwart, M; IJzerman, AP; Jacobson, KA; Kim, YC; Melman, N; Moro, S; von Frijtag Drabbe Künzel, JK | 1 |
| Castelhano, AL; Ma, C; MacLennan, SJ; McKibben, B; Song, JP; Steinig, AG; Stewart, M | 1 |
| Andreini, M; Baraldi, PG; Bernardini, C; Borea, PA; Botta, M; Corelli, F; Fruttarolo, F; Martinelli, A; Ortore, G; Tafi, A; Tuccinardi, T | 1 |
| Algarra, M; Brea, J; Cai, C; Hierrezuelo, J; Isabel Loza, M; Manuel López-Romero, J; Rico, R | 1 |
| Cheong, SL; Federico, S; Paira, P; Pastorin, G; Shao, YM; Spalluto, G; Venkatesan, G; Yap, CW | 1 |
| Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L | 1 |
| Jang, HS; Kerkvliet, NI; Kolluri, SK; Liefwalker, DF; O'Donnell, EF | 1 |
Reviews
1 review(s) available for cgs 15943 and mrs 1220
| Article | Year |
|---|---|
Fluorescent ligands for adenosine receptors.
Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2013 |
Other Studies
7 other study(ies) available for cgs 15943 and mrs 1220
| Article | Year |
|---|---|
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
Topics: Adenosine; Affinity Labels; Animals; Binding Sites; Binding, Competitive; Cell Line; Cerebral Cortex; Corpus Striatum; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Substrate Specificity; Triazoles | 1996 |
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Topics: Animals; Cerebral Cortex; CHO Cells; Cricetinae; Cyclic AMP; Humans; Models, Molecular; Molecular Conformation; Protein Conformation; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Triazoles | 1998 |
[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors.
Topics: Adenosine A2 Receptor Antagonists; Cells, Cultured; Humans; Pyrimidines; Pyrroles; Radioligand Assay; Time Factors; Tritium | 2004 |
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.
Topics: Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Design; Furans; Humans; Models, Molecular; Molecular Structure; Pyrazoles; Pyrimidines; Radioligand Assay; Receptor, Adenosine A3; Thermodynamics; Triazoles | 2006 |
Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors.
Topics: Binding, Competitive; Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Theophylline | 2010 |
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.
Topics: Adenosine A3 Receptor Antagonists; Humans; Models, Molecular; Molecular Structure; Protein Binding; Pyrazoles; Pyrimidines; Quantitative Structure-Activity Relationship; Triazoles | 2011 |
Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line, Tumor; Fas Ligand Protein; Humans; Ligands; Mice; Quinazolines; Receptors, Aryl Hydrocarbon; Signal Transduction; Small Molecule Libraries; Transcriptional Activation; Triazoles | 2021 |